Seeing Is Believing
Currently out of the existing stock ratings of Ed Arce, 292 are a BUY (82.49%), 56 are a HOLD (15.82%), 6 are a SELL (1.69%).
Analyst Ed Arce works with a stock forecast success ratio of 29.85% fulfilled within 104.74 days on average. Previously, Ed Arce worked at HCWAINWRIGHT.
Ed Arce’s has documented 692 price targets and ratings displayed on 39 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ITRM, Iterum Therapeutics PLC at 30-Apr-2024.
Analyst best performing recommendations are on CDTX (CIDARA THERAPEUTICS).
The best stock recommendation documented was for CDTX (CIDARA THERAPEUTICS) at 4/8/2024. The price target of $6 was fulfilled within 15 days with a profit of $4.93 (460.75%) receiving and performance score of 307.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
11
$7.5 (214.29%)
11
28 days ago
0/9 (0%)
$7.47 (211.61%)
Which stock is Ed Arce is most bullish on?
Which stock is Ed Arce is most reserved on?
What Year was the first public recommendation made by Ed Arce?